Levosulpiride-d3

• Description :

  Levosulpiride-d3 is the deuterium labeled Levosulpiride. Levosulpiride (RV-12309) is the (S) -enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic agent of the benzamide class[1][2].

• Product Name Alternative :

  RV-12309-d3; S- (-) -Sulpiride-d3

• UNSPSC :

  12352005

• Target :

  5-HT Receptor; Dopamine Receptor; Isotope-Labeled Compounds

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling; Others

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Metabolic Disease; Neurological Disease

• Purity :

  99.79

• Solubility :

  10 mM in DMSO|DMSO : 50mg/mL (ultrasonic)

• Smiles :

  C(NC[C@H]1N(CC)CCC1)(=O)C2=C(OC([2H])([2H])[2H])C=CC(S(N)(=O)=O)=C2

• Molecular Formula :

  C15H20D3N3O4S

• Molecular Weight :

  344.44

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Triebel J, et al. From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis. Front Endocrinol (Lausanne) . 2017;8:342. Published 2017 Dec 11.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• Isoform :

  D3 Receptor

• CAS Number :

  [124020-27-5]